Please sign in to follow a disease.
Mindfulness may rewire depressed brains, small study hints
NCT ID NCT05585775
First seen Jun 26, 2026 · Last updated Jul 07, 2026 · Updated 3 times
Summary
This study looks at whether mindfulness-based cognitive therapy (MBCT) can improve how the brain controls emotions in people with mild depression symptoms. 76 adults with depression in remission will be randomly assigned to either MBCT or a wellness program. Researchers will use computer tasks and surveys to measure changes in emotional thinking and mood over time.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Mindfulness-Based Cognitive Therapy (MBCT)
- What this could lead to
- If successful, this could reveal how MBCT works in the brain to ease depression, pointing toward more targeted treatments.
- What could go wrong
- This is a small, early-stage study focused on brain processes, not a direct treatment test. Results may not lead to new therapies or apply to everyone with depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 76 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2023
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Adults 18 years or older 2. English fluency in order to complete study procedures 3. Normal vision or corrected to normal vision 4. QIDS score ≥ 5 and ≤ 15 to include individuals with elevated, but not severe symptoms of depression 5. No presence of psychotic symptoms that interfere with functioning 6. No current hazardous alcohol or drug use 7. No previous experience with mindfulness-based treatment (i.e., enrollment in MBSR or MBCT previously) 8. No current symptoms of mania indicative of a manic episode 9. No current cognitive impairment 10. No history of a formally diagnosed learning disability in reading, intellectual disability or other developmental disorder 11. No history of a neurologic illness affecting cognition 12. If on psychiatric medications, no change in medications for at least 4 weeks 13. If in psychotherapy, no change in therapy status for at least 4 weeks Exclusion Criteria: Exclusion criteria include: (a) presence of psychotic symptoms that interfere with one's ability to function as determined by the SCID-5 Psychotic Screening Module; (b) current hazardous alcohol or drug use as indicated by a score of \>10 for men and women on the AUDIT and the DUDIT for cannabis use, and \>6 for men and women on the DUDIT for all other drugs (everything but cannabis), (c) change in psychiatric drug prescription within 4 weeks; (d) started psychotherapy or other psychiatric treatment within the past 4 weeks; (e) current suicide ideation or behavior which requires urgent intervention due to safety concerns; (f) Previous enrollment in MBCT or MBSR; (g) symptoms of mild cognitive impairment as indicated by a score of \<26 on the MoCA; (h) formally diagnosed learning disability, intellectual disability, or other developmental disorder; (i) history of neurologic illness affecting cognition; (j) current symptoms indicative of a manic episode per the SCID-5 Mood Disorders Module.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Depression are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Butler Hospital
Providence, Rhode Island, 02906, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Gut bacteria may hold clues to dozens of diseases
- Can a Text-Message program help trauma survivors avoid PTSD and depression?
- Can a website help young people understand depression?
- Can a brain scan and your phone predict where depression goes next?
- Can a tailored therapy ease anxiety and depression in autistic teens?
- Reading the Brain's signals to predict who benefits from deep brain stimulation